Market Size of Latin America Liver Cancer Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.90 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Latin America Liver Cancer Treatment Market Analysis
The Latin American liver cancer treatment market is expected to register a CAGR of nearly 7.9% during the forecast period. Changes in the current lifestyle of individuals led to the exposure of a large amount of population to the risk factors that contribute to liver cancer. The risk factors include hepatitis (caused by either the hepatitis B or hepatitis C virus), type-2 diabetes, metabolic disorders, excess body weight, alcohol consumption, and tobacco smoking. It has also been observed that liver cancer risk increases substantially with the increase in one's body mass index (BMI). According to the OECD Obesity Update 2017, obesity levels are particularly high in Latin American countries. For example, in Mexico, 32.4% of males aged 15 years and over are obese as of 2017, and nearly 39% of the population is projected to become obese by 2030. Thus, owing to the above factors, the market is expected to show growth in the near future.
